Mesh Bio

Mesh Bio is a digital health startup based in Singapore, founded in 2018 by healthcare professionals and data scientists.

The company focuses on transforming chronic disease management, particularly for metabolic conditions like diabetes and cardiovascular disease, through predictive analytics, artificial intelligence, and digital twin technology. Mesh Bio serves the B2B HealthTech market, providing cloud-based solutions to healthcare providers and stakeholders across Southeast Asia. The company's flagship product, DARA®, is a real-time health intelligence platform that aggregates medical history, lab results, and imaging data to support clinical decision-making. Additionally, Mesh Bio offers HealthVector® Diabetes, a predictive analytics solution aimed at early identification and management of diabetes-related complications. Their services also include AI-powered clinical decision support tools and digital twin models to personalize treatment plans and optimize care delivery. With a mission to enhance patient engagement and health outcomes, Mesh Bio is positioned as a key innovator in the healthcare landscape.